RecallDepth
Class III Terminated

DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill in a 6 mL vial, Single Dose Vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047. NDC: 63323-883-05

Company
Fresenius Kabi Usa, Llc
Recall Initiated
November 17, 2020
Posted
December 2, 2020
Recall Number
D-0105-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
16,986 vials
Firm Location
Lake Zurich, IL, United States

Reason for Recall

Cross Contamination with Other Products: trace amounts of octreotide found during testing

Distribution

Nationwide USA and Puerto Rico

Lot / Code Info

Batch: 6120525, exp 11/2020

More recalls by Fresenius Kabi Usa, Llc

View all recalls by this company →

Other recent Class III Drug recalls